CIS/Index
Copyright © 2001, Congressional Information
Service, Inc.
1 CIS H 36142
TITLE: Human
Cloning Prohibition Act of 2001 and the Cloning Prohibition Act of 2001
CIS-NO: 2001-H361-42
SOURCE: Committee on Energy and
Commerce. House
DOC-TYPE: Hearing
Retrieve
the full text of testimony DATE: June 20, 2001
LENGTH:
iii+110 p.
CONG-SESS: 107-1
ITEM-NO: 1019-A-01; 1019-B-01
SUDOC: Y4.C73/8:107-41
GPO-STOCK-NO:
552-070-27386-7.
SUMMARY: Committee Serial No.
107-41. Hearing before the Subcom on Health to consider the following bills to
prohibit
human cloning: H.R. 1644, the
Human Cloning Prohibition Act of 2001, to prohibit all forms of
human cloning and shipping, receiving, or importing a product
of
human cloning. H.R. 2172, the Cloning
Prohibition Act of 2001, to amend the Federal Food, Drug, and Cosmetic Act to
prohibit the use of
human cloning to initiate a pregnancy and
the shipment or transportation of a product of
human cloning if
the product is intended to initiate a pregnancy.
CONTENT-NOTATION: Human cloning
prohibition estab
BILLS: 107
H.R. 1644;
107
H.R. 2172 DESCRIPTORS:
SUBCOM ON HEALTH, ENERGY AND COMMERCE. HOUSE;
BIOTECHNOLOGY; BIOLOGICAL RESEARCH; GENETICS; MEDICAL ETHICS; MEDICAL
REGULATION;
HUMAN CLONING PROHIBITION ACT; CLONING PROHIBITION
ACT; FEDERAL FOOD, DRUG, AND COSMETIC ACT
01-H361-42 TESTIMONY NO: 1
June 20, 2001 p. 20-44
WITNESSES (and witness
notations):
ALLEN, CLAUDE A. (Deputy Secretary, HHS)
STATEMENT AND DISCUSSION:
Opposition to all
forms of
human cloning, in light of consideration of H.R. 1644
and H.R. 2172.
CONTENT NOTATION:
Human cloning prohibition estab
TESTIMONY DESCRIPTORS:
DEPARTMENT OF HEALTH
AND HUMAN SERVICES
01-H361-42 TESTIMONY NO: 2
June 20, 2001 p. 45-110
WITNESSES (and witness
notations):
OKARMA, THOMAS B. (President and CEO, Geron
Corp.; also representing Biotechnology Industry Organization)
KASS, LEON R. (Professor, Committee on Social Thought and
the College, University of Chicago)
GUENIN, LOUIS M.
(Lecturer, Ethics in Science, Department of Microbiology and Molecular Genetics,
Harvard Medical School)
NEWMAN, STUART A. (Professor, Cell
Biology and Anatomy, New York Medical College)
PERRY,
DANIEL (Executive Director, Alliance for Aging Research)
NORSIGIAN, JUDY (Executive Director, Boston Women's Health
Book Collective)
DOERFLINGER, RICHARD M. (Associate
Director, Policy Development, Secretariat for Pro-Life Activities, National
Conference of Catholic Bishops)
FUKUYAMA, FRANCIS
(Professor, Public Policy, George Mason University)
STATEMENTS
AND DISCUSSION:
Opposing perspectives on H.R. 1644 and
H.R. 2172; differing views on ethical issues involved in consideration of
human cloning; importance of cloning involving tissue
generation and genetic cell replication in medical research; concerns that
legalization of any type of cloning might lead to reproductive cloning;
elaboration on issues related to H.R. 1644 and H.R. 2172.
CONTENT
NOTATION:
Human cloning prohibition estab
TESTIMONY DESCRIPTORS:
GERON CORP.;
BIOTECHNOLOGY INDUSTRY ORGANIZATION; ALLIANCE FOR AGING RESEARCH; BOSTON WOMEN'S
HEALTH BOOK COLLECTIVE; NATIONAL CONFERENCE OF CATHOLIC BISHOPS
LOAD-DATE: November 22, 2002